{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:00:05Z","timestamp":1791172805178,"version":"4.1.0"},"reference-count":87,"publisher":"Informa UK Limited","issue":"12","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Paul Calabresi K12","award":["5K12CA138464"],"award-info":[{"award-number":["5K12CA138464"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Pharmacology"],"published-print":{"date-parts":[[2025,12,2]]},"DOI":"10.1080\/17512433.2025.2600408","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T12:13:40Z","timestamp":1764850420000},"page":"1005-1017","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["The importance of specificity of drug treatment in head and neck cancer: current developments in personalized medicine to improve safety and tolerability"],"prefix":"10.1080","volume":"18","author":[{"given":"Brenna","family":"Champlin","sequence":"first","affiliation":[{"name":"University of California","place":["Sacramento, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Keefe","sequence":"additional","affiliation":[{"name":"University of California","place":["Sacramento, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Birkeland","sequence":"additional","affiliation":[{"name":"University of California","place":["Sacramento, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiruyeh","family":"Schokrpur","sequence":"additional","affiliation":[{"name":"University of California","place":["Sacramento, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21871"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-019-0662-5"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-3541"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-24-02194"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1602252"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30066-3"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32591-7"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02508"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.29245\/2578-2967\/2021\/1.1190"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1577509"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02198"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2022.101375"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.756506"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar3593"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.10.434"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.6024"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.6017"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.24.00646"},{"issue":"3","key":"e_1_3_5_22_1","first-page":"227","article-title":"Neoadjuvant and adjuvant nivolumab in resectable head and neck cancer","volume":"390","author":"Uppaluri R","year":"2024","unstructured":"Uppaluri R, Campbell KM, Egloff AM, et al. Neoadjuvant and adjuvant nivolumab in resectable head and neck cancer. N Engl J Med. 2024;390(3):227\u2013239.","journal-title":"N Engl J Med"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.17_suppl.LBA2"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.04.001"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.12.008"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-024-03643-3"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2023.0147"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00100-1"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.08.029"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00332"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.1483"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.TPS6589"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.TPS6090"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2025-CT001"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2024.01.016"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.07.011"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2017.08.276"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2023.5550"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005573"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1039\/D4RA07193J"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2020-206466"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathol.2024.06.006"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31999-8"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242216386"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.26542"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.18542"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2018.04.008"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2017-0674"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30421-7"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0912217"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.677900"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2025.0081"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2018-0405"},{"key":"e_1_3_5_54_1","unstructured":"University of Chicago. A phase II trial of carboplatin paclitaxel and nivolumab induction therapy followed by response-stratified locoregional therapy for patients with locally advanced HPV-negative head and neck cancer. The depend trial. ClinicalTrials.gov. 2025 [cited 2025 Jun 11]. Report No.: NCT03944915. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03944915"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1508885"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01522-4"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-023-01499-1"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.09.2000"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-25-0210"},{"key":"e_1_3_5_60_1","unstructured":"Merck Sharp & Dohme LLC. A phase 3 randomized placebo-controlled double-blind clinical study of pembrolizumab (MK-3475) with or without lenvatinib (E7080\/MK-7902) to evaluate the safety and efficacy of pembrolizumab and lenvatinib as 1L intervention in a PD-L1 selected population of participants with recurrent or metastatic head and neck squamous cell carcinoma (R\/M HNSCC) (LEAP-010). Report no.: NCT04199104. Available from clinicaltrials.gov; 2025 [cited 2025 Jun 11]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04199104"},{"key":"e_1_3_5_61_1","unstructured":"Merck provides update on KeyVibe and KEYFORM clinical development programs evaluating investigational vibostolimab and favezelimab fixed-dose combinations with pembrolizumab [internet]. Merck.com. [cited 2025 Jun 11]. Available from: https:\/\/www.merck.com\/news\/merck-provides-update-on-keyvibe-and-keyform-clinical-development-programs-evaluating-investigational-vibostolimab-and-favezelimab-fixed-dose-combinations-with-pembrolizumab\/"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy495"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13133119"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2019-0244"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-023-00984-4"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-04937-x"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.672677"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1002\/hed.26997"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-84890-3"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1557652"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2013.03.010"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13051162"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-009573"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22031402"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.83824"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2025.1604313"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33123"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56462-0"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-022-01024-y"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-21-4425"},{"key":"e_1_3_5_81_1","unstructured":"Bicara Therapeutics. First-in-human phase 1\/1b open-label multicenter study of bifunctional EGFR\/TGF\u03b2 fusion protein BCA101 monotherapy and in combination therapy in patients with EGFR-driven advanced solid tumors [internet]. Report no.: NCT04429542. Available from clinicaltrials.gov; 2025 [cited 2025 Jun 26]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04429542"},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.16_suppl.2513"},{"key":"e_1_3_5_83_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.6005"},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2035807"},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.1111\/cas.70176"},{"key":"e_1_3_5_86_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.4c06930"},{"key":"e_1_3_5_87_1","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202107877"},{"key":"e_1_3_5_88_1","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2020.1799350"},{"key":"e_1_3_5_89_1","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202502154"}],"container-title":["Expert Review of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17512433.2025.2600408","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T14:01:22Z","timestamp":1767362482000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17512433.2025.2600408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":87,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12,2]]}},"alternative-id":["10.1080\/17512433.2025.2600408"],"URL":"https:\/\/doi.org\/10.1080\/17512433.2025.2600408","relation":{},"ISSN":["1751-2433","1751-2441"],"issn-type":[{"value":"1751-2433","type":"print"},{"value":"1751-2441","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-06-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}